Search

Search Results

• 

  Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?

  Beatrice Maranini, Roberta Foti, Moustapha Taha, Veronica Venturelli, Andrea Lo Monaco, Marcello Govoni

  29-01-2025

  https://doi.org/10.4081/reumatismo.2025.1754

  2326

  PDF: 471

  SUPPLEMENTARY MATERIAL: 171
• 

  Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis

  I. Olivieri, Salvatore D'Angelo, C. Palazzi, P. Leccese, A. Nigro, A. Padula

  1-3

  28-03-2013

  https://doi.org/10.4081/reumatismo.2013.1

  2404

  PDF: 820
• 

  Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

  Stefano Stano, Fabio Cacciapaglia, Laura Coladonato, Giuseppe Lopalco, Florenzo Iannone, Marco Fornaro

  07-04-2025

  https://doi.org/10.4081/reumatismo.2025.1817

  2289

  PDF: 469

  SUPPLEMENTARY MATERIAL: 346
• 

  Patients with anti-small ubiquitin-like modifier activating enzyme-positive dermatomyositis resembling antisynthetase syndrome with poor prognosis: a bicentric international retrospective study and literature review

  Camila Gusmão Vicente de Carvalho, Barbara Bayeh, Fernando Henrique Carlos de Souza, Renata Miossi, Pleiades Tiharu Inaoka, Takashi Matsushita, Naoki Mugii, Samuel Katsuyuki Shinjo

  09-10-2024

  https://doi.org/10.4081/reumatismo.2024.1686

  3145

  PDF: 533
• 

  Cryptogenic stroke and seronegative antiphospholipid syndrome: a case series of patients with positivity for “non-criteria” antiphospholipid antibodies

  S. Mancuso, M. De Michele, S. Truglia, A. Capozzi, L. Rapino, I. Berto, C. Alessandri, D. Toni, V. Manganelli, M. Sorice, F. Conti

  25-09-2024

  https://doi.org/10.4081/reumatismo.2024.1701

  1213

  PDF: 392
• 

  Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

  M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali

  17-07-2023

  https://doi.org/10.4081/reumatismo.2023.1544

  1425

  PDF: 777
• 

  Elbow monoarthritis: an atypical onset of juvenile idiopathic arthritis

  A. Marino, I. Pagnini, S. Savelli, D. Moretti, G. Simonini, R. Cimaz

  175-179

  19-07-2012

  https://doi.org/10.4081/reumatismo.2012.175

  1144

  PDF (Italian): 682
• 

  Rheumatology research output in the Arab World: despite the challenges

  G. El Hasbani, A.S.M. Jawad, I. Uthman

  29-12-2022

  https://doi.org/10.4081/reumatismo.2022.1520

  1198

  PDF: 655

• Disease activity assessment for juvenile idiopathic arthritis in transitional care

  F. La Torre, C. Coppola, M.G. Anelli, F. Cacciapaglia, G. Lopalco, F. Cardinale, F. Iannone

  24-06-2024

  https://doi.org/10.4081/reumatismo.2024.1638

  2043

  PDF: 937
• 

  Vasculitis associated with adenosine deaminase 2 deficiency: at the crossroads between Behçet’s disease and autoinflammation. A viewpoint

  A. Colangelo, F. Tromby, G. Cafaro, R. Gerli, E. Bartoloni, C. Perricone

  18-09-2023

  https://doi.org/10.4081/reumatismo.2023.1578

  2033

  PDF: 1218
• 

  Psoriasis and family history of psoriasis may not affect disease severity of rheumatoid arthritis

  N. Şen, R. Mercan, G. Geçmez, B. Ediz, O. Volkan, S. Yilmaz-Oner, M.E. Tezcan

  07-02-2022

  https://doi.org/10.4081/reumatismo.2021.1453

  6125

  PDF: 843
• 

  Rheumatologic rehabilitation: towards recommendations

  S. Maddali Bongi, A. Del Rosso, M. Matucci Cerinic

  197-207

  06-11-2014

  https://doi.org/10.4081/reumatismo.2014.722

  2279

  PDF: 1382
• 

  The prevalence and clinical spectrum of post-Covid syndrome in patients with rheumatic diseases: a single-center experience

  S. Batıbay, R. Koçak Ulucaköy, Z. Günendi, F. Göğüş

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1481

  2586

  PDF: 786
• 

  Tuberculosis infection in patients with dermatomyositis

  Luis Carlos Palomino Romero, Alfredo Vargas Caselles, Natalia Soledad Rius, Enrique Soriano, Javier Rosa, Marina Scolnik

  07-03-2025

  https://doi.org/10.4081/reumatismo.2025.1631

  1254

  PDF: 275

• Pregnancy in patients affected by axial-spondyloarthritis: a narrative review of disease activity and obstetric outcomes

  M. Filippini, G. Fontana, P. Bizioli, F. Crisafulli, R. Orabona, S. Zatti, F. Franceschini, A. Tincani

  11-09-2024

  https://doi.org/10.4081/reumatismo.2024.1697

  1758

  PDF: 729
• 

  A clinical overview of bone marrow edema

  M. Manara, M. Varenna

  184-196

  28-07-2014

  https://doi.org/10.4081/reumatismo.2014.790

  12154

  PDF: 6076

• The heterogeneity of lung involvement in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: a case of hypersensitivity pneumonitis-like pattern

  C. Iannone, M.R. Pellico, C. Campochiaro, L. Tescaro, M. Zompatori, A. Caminati, S. Harari, R. Caporali

  24-06-2024

  https://doi.org/10.4081/reumatismo.2024.1611

  1643

  PDF: 749
• 

  Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis recurrence temporally associated with allergen-specific immunotherapy in a female adolescent: a case report

  C. Granjo Morais, A. Martins, S. Ganhão, F. Aguiar, M. Rodrigues, I. Brito

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1594

  1884

  PDF: 588
• 

  Pulmonary cavitary lesions may be one of the presenting features in Ig A nephropathy

  B. Isci, T.S. Gamsiz, S. Kayipmaz, O. Keskin, M.E. Tezcan

  111-114

  06-07-2018

  https://doi.org/10.4081/reumatismo.2018.1037

  1448

  PDF: 757
• 

  Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients

  S. Canestri, M.C. Totaro, E. Serone, B. Tolusso, D. Frezza, E. Gremese, G. Ferraccioli

  368-373

  20-12-2012

  https://doi.org/10.4081/reumatismo.2012.368

  2531

  PDF: 907
• 

  Coexistence of sarcoidosis and Hashimoto thyroiditis

  H. Semiz, M. Yalcin, S. Kobak

  106-110

  06-07-2018

  https://doi.org/10.4081/reumatismo.2018.1017

  2714

  PDF: 1693
• 

  Predictors of thickened carotid intima media thickness among well controlled lupus nephritis patients in a Malaysian tertiary centre

  S.S. Shaharir, M.S. Mohamed Said, N.CT. Kong

  341-349

  20-12-2012

  https://doi.org/10.4081/reumatismo.2012.341

  2491

  PDF: 995
• 

  Uveitis in patients with oligoarticular juvenile idiopathic arthritis and juvenile spondyloarthritis/enthesitis related arthritis: is there any difference?

  A. Martins, S. Ganhão, F. Oliveira Pinheiro, C. Granjo Morais, M. Rodrigues, M. Leuzinger-Dias , L. Figueira, I. Brito

  08-05-2023

  https://doi.org/10.4081/reumatismo.2023.1561

  1624

  PDF: 634
• 

  Predictors of poor outcomes in juvenile dermatomyositis: what do we know? A narrative review

  Ana Martins, Sara Ganhão, Francisca Aguiar, Mariana Rodrigues, Iva Brito

  11-11-2024

  https://doi.org/10.4081/reumatismo.2024.1640

  2006

  PDF: 723
• 

  Denosumab for the treatment of HIV-associated osteoporosis with fractures in a premenopausal woman

  E. Marasco, M. Mussa, F. Motta, F. Bobbio-Pallavicini, R. Maserati, C. Montecucco, L. Bogliolo

  54-58

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1358

  6115

  PDF: 1015
• 

  Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs

  F.M. Perrotta, O. Addimanda, R. Ramonda, S. D’Angelo, E. Lubrano, A. Marchesoni, I. Olivieri, L. Punzi, C. Salvarani, A. Spadaro

  208-214

  06-11-2014

  https://doi.org/10.4081/reumatismo.2014.756

  2937

  PDF: 1612
• 

  Idiopathic inflammatory myopathies linked to vaccination against SARS-CoV-2: a systematic review

  A. Camargo-Coronel, H. Quiñones-Moya; M.R. Hernández-Zavala; J.R. Hernández-Vázquez, M.Á. Vázquez-Zaragoza

  08-05-2023

  https://doi.org/10.4081/reumatismo.2023.1548

  2385

  PDF: 1866
• 

  Cervical myelopathy as an atypical presentation of antineutrophil cytoplasmic antibody-associated vasculitis in a patient affected by silicosis: a case report and literature overview

  S. Grazzini, R. Terribili, E. Conticini, S. Bartalini, L. Cantarini, B. Frediani

  24-09-2024

  https://doi.org/10.4081/reumatismo.2024.1702

  1227

  PDF: 411
• 

  Treat-to-target (T2T) of serum urate (SUA) in gout: a clinical audit in real-world gout patients

  C.L. Teh, Y.K. Cheong, S.A. Wan, G.R. Ling

  154-159

  24-10-2019

  https://doi.org/10.4081/reumatismo.2019.1225

  2212

  PDF: 1279
• 

  Diagnostic utility of serum melatonin levels in systemic lupus erythematosus: a case-control study

  A.B. Rasheed, M.S. Daoud, F.I. Gorial

  170-174

  21-12-2017

  https://doi.org/10.4081/reumatismo.2017.998

  2165

  PDF: 896
• 

  Management of giant cell arteritis among general practitioners from Genoa, Italy: a web-based survey

  P. Clini, A. Stimamiglio , D. Camellino, E. Hysa, M. Cutolo, M.A. Cimmino

  207-212

  18-01-2021

  https://doi.org/10.4081/reumatismo.2020.1291

  3538

  PDF: 666
• 

  Development of Hodgkin lymphoma in a patient with sarcoidosis

  F. Gediz, A.F. Yilmaz, B. Payzin, T. Yuksel, A.O. Calli, S. Kobak

  84-87

  03-08-2017

  https://doi.org/10.4081/reumatismo.2017.916

  1835

  PDF: 938
• 

  Is there a reliable association between patient-reported limb claudication and vascular imaging methods in Takayasu arteritis?

  C.S.R. Araujo, A.M. dos Santos, P.A. Olivo Pallo, R.M.R. Pereira, S.K. Shinjo

  103-110

  23-07-2020

  https://doi.org/10.4081/reumatismo.2020.1277

  991

  PDF: 599
• 

  Relationship between patient-reported and objective measurements of hand function in patients with rheumatoid arthritis

  S.M. Günay, Z. Tuna, D. Oskay

  183-187

  31-12-2016

  https://doi.org/10.4081/reumatismo.2016.943

  2166

  PDF: 1206
• 

  Myasthenic syndrome in systemic lupus erythematosus successfully treated with plasma exchange: through one of the unexplored faces of neuropsychiatric involvement

  Sara Ferrigno, Immacolata Prevete, Valeria Orefice, Chiara Scirocco, Gian Domenico Sebastiani

  08-04-2026

  https://doi.org/10.4081/reumatismo.2026.1956

  478

  PDF: 66
• 

  Erythema nodosum after COVID-19 vaccine

  B. Maranini, G. Ciancio, M. Corazza, F. Ruffilli, G. Galoppini, M. Govoni

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1475

  3020

  PDF: 1314
• 

  Is there an association between upper limb claudication and handgrip strength in Takayasu arteritis?

  A.M. dos Santos, R.G. Misse, I.B.P. Borges, R.M.R. Pereira, S.K. Shinjo

  197-206

  18-01-2021

  https://doi.org/10.4081/reumatismo.2020.1298

  1139

  PDF: 670
• 

  Histopathology of the muscle in rheumatic diseases

  S. Barsotti, A. Tripoli, L.E. Pollina, M. Mosca, R. Neri

  133-145

  03-10-2018

  https://doi.org/10.4081/reumatismo.2018.1051

  1682

  PDF: 1408
• 

  First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome

  B. Palterer, G. Vitiello, D. Cammelli

  75-77

  03-08-2017

  https://doi.org/10.4081/reumatismo.2017.923

  2031

  PDF: 977
• 

  Far infrared emitting plaster in knee osteoarthritis: a single blinded, randomised clinical trial

  GL. Bagnato, G. Miceli, M. Atteritano, N. Marino, GF. Bagnato

  388-394

  20-12-2012

  https://doi.org/10.4081/reumatismo.2012.388

  5368

  PDF: 2890
• 

  Antisynthetase syndrome with anti-glycyl tRNA synthetase antibodies in a patient with axial spondyloarthritis treated with tumor necrosis factor-α inhibitors

  Maria Iacovantuono, Chiara Bonini, Ernesto Di Biase, Vinicio Magliacani, Gian Domenico Sebastiani

  10-02-2025

  https://doi.org/10.4081/reumatismo.2025.1756

  1438

  PDF: 293
• 

  Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

  M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

  143-166

  31-10-2013

  https://doi.org/10.4081/reumatismo.2013.143

  7561

  PDF: 2789
• 

  Computed tomography of interstitial lung disease in systemic sclerosis: dataset and deep learning model for pulmonary lesion segmentation

  Amir M. Vahdani, Aida Mohamadi, Sepehr Nayebirad, Shayan Forghani, Elaheh Karimi, Yousef Vojgani, Zahra Tamartash, Mehrnaz Asadi, Leila Aghaghazvini, Farhad Gharibdoost, Hoda Kavosi

  25-02-2026

  https://doi.org/10.4081/reumatismo.2026.1920

  1093

  PDF: 75

  SUPPLEMENTARY MATERIAL: 33
• 

  Superior oblique tendon (Brown’s) syndrome as the presenting finding in childhood onset HLA-B27-related enthesitis and juvenile idiopathic oligoarticular arthritis

  C. Pham, V. Utz, A. Marcotty, A. Zeft, P. Rychwalski

  240-244

  06-11-2014

  https://doi.org/10.4081/reumatismo.2014.750

  2381

  PDF: 1001
• 

  Rare in the rare: Kikuchi-Fujimoto disease associated with connective tissue disorders. A report of our experience

  Carmela Coccia, Gemma Lepri, Juela Levani, Silvia Bellando Randone, Serena Guiducci

  04-08-2025

  https://doi.org/10.4081/reumatismo.2025.1853

  1361

  PDF: 172
• 

  Evaluation of a psychoeducational intervention including emotional intelligence to increase treatment adherence in rheumatoid arthritis (A pilot study)

  E. Cárdenas-Cloud, A.J.L. Brambila-Tapia, R.M. Meda-Lara, F.d.J. Pérez-Vázquez, E. Chavarría-Ávila, F.J. Romero-Abundis, M. Vázquez-del-Mercado

  22-11-2021

  https://doi.org/10.4081/reumatismo.2021.1400

  2876

  PDF: 902

• PO:33:200 | Analysis of risk factors associated with vertebral fractures in systemic sclerosis: evidence from the "Sclero-RER" study group Alessandra Bezzi¹, Federica Lumetti², Martina Orlandi³, Fabio Mascella¹, Maria Cristina Focherini¹, Eugenio Arrigoni⁴, Elena Bravi⁴, Andrea Lo Monaco⁵, Amelia Spinella³, Ottavio Secchi³, Gianluigi Bajocchi⁶, Francesco Girelli⁷, Francesco Ursini⁸, Pierluigi Cataleta⁹, Massimo Reta¹⁰, Alarico Ariani^11|12, Dilia Giuggioli³ | ¹Internal Medicine and Rheumatology Unit, AUSL Romagna, Rimini ²AUSL of Modena and Rheumatology Unit, University Hospital Policlinico of Modena; ³Rheumatology Unit, University of Modena and Reggio Emilia; ⁴Rheumatology Unit, Guglielmo da Saliceto Hospital, Piacenza; ⁵Rheumatology, department of medical sciences, University of Ferrara; ⁶Rheumatology Unit, IRCCS Arcispedale Santa Maria Nuova Reggio Emilia; ⁷Rheumatology Unit, G.B. Morgagni - L. Pierantoni Hospital, Forlì; ⁸Rizzoli Orthopedic Institute, Rheumatology Unit, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum Bologna; ⁹Hospital Santa Maria delle Croci, Rheumatology Unit, Department of Internal medicine, AUSL-Romagna Ravenna; ¹⁰Rheumatology Unit, AUSL of Bologna, Sant'Orsola Polyclinic Hospital, AOU IRCCS of Bologna; ¹¹Internal Medicine and Rheumatology Unit, University Hospital of Parma; ¹²AUSL Bologna and University of Bologna, IRCCS Policlinico Sant'Orsola, Bologna, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2208

  142

• CO:01:4 | Identify predictors of relapse in idiopathic inflammatory myopathies: insights from an international cohort Cristina Bochicchio^1|2, Maria Rosa Pellico^1|2, Claudia Iannone^1|2, Lekshmi Minikumari Rahulan³, Marco Fornaro⁴, Ilaria Cavazzana⁵, Edoardo Conticini⁶, Musataka Musataka⁷, Akira Yoshida⁷, Silvia Cavalli^1|2, Silvia Grazzini⁶, Giulio Fraticelli⁸, Alessia Gatti⁵, Giulio Lopinto⁴, Paolo Semeraro⁵, Veronica Batani⁸, Thomas Patric Sheeran⁹, Florenzo Iannone⁴, Giacomo De Luca⁸, Roberto Caporali^1|2, Latika Gupta^9|10|11, Nicoletta Del Papa². | ¹Department of Clinical Sciences and Community Health, University of Milano; ²Department of Rheumatology and Medical Sciences, ASST Gaetano Pini-CTO Institute, Milano, Italy; ³Rheumatology "Sanjay Gandhi" Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India; ⁴Unit of Rheumatology, Department of Precision and Regenerative Medicine, Area Jonica, University of Bari; ⁵Rheumatology and Clinical Immunology Unit, ASST Spedali Civili di Brescia; ⁶Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy; ⁷Department of Allergy and Rheumatology Nippon Medical School Graduate School of Medicine, Tokyo, Japan; ⁸Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano, Italy; ⁹Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK; ¹⁰Francis Crick Institute, London, UK; ¹¹School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, UK

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1964

  215
• 

  Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

  L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

  224-232

  06-11-2014

  https://doi.org/10.4081/reumatismo.2014.748

  2586

  PDF: 1668
• 

  To prophylax or not to prophylax? The role of trimethoprim/sulfamethoxazole as a prophylactic agent in systemic vasculitis: the case of antineutrophil cytoplasmic antibody-associated vasculitis and giant cell arteritis

  Alessandro Tomelleri, Christian Dejaco, Milena Bond

  13-02-2025

  https://doi.org/10.4081/reumatismo.2025.1791

  1652

  PDF: 528